Conditions: Lower Urinary Tract Symptoms (LUTS)
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 404
Healthy volunteers: no

Brief summary:
A dose-finding, multi-centre, double-blind, randomised, parallel, placebo-controlled trial to investigate efficacy and safety of degarelix in men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None

Interventions: intervention 1: Placebo intervention 2: Degarelix 10 mg intervention 3: Degarelix 20 mg intervention 4: Degarelix 30 mg
Intervention descriptions: intervention 1: Mannitol 50 mg/mL solution intervention 2: 10 mg degarelix, 40 mg/mL solution intervention 3: 20 mg degarelix, 40 mg/mL solution intervention 4: 30 mg degarelix, 40 mg/mL solution

Protocol document: